Trubion Finds Kindred Spirit in Facet For Co-Development And Commercialization
This article was originally published in The Pink Sheet Daily
Executive Summary
Recently launched spinout from PDL BioPharma pays $20 million upfront to Trubion for chronic lymphocytic leukemia candidate.